Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jan;281(1):81-5.
doi: 10.1007/s00404-009-1073-5. Epub 2009 Apr 9.

Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART

Affiliations
Randomized Controlled Trial

Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART

Razieh Dehghani Firouzabadi et al. Arch Gynecol Obstet. 2010 Jan.

Abstract

Purpose: This prospective study evaluated the efficacy of gonadotropin-releasing hormone (GnRH) antagonist protocol in comparison with the GnRH agonist protocol in the first cycle of assisted reproductive technique (ART).

Methods: We randomized 235 patients undergoing ART for the first time. The first group was stimulated with a standard long protocol and the second group stimulated with GnRH antagonis.

Results: There was no statistically significant difference in the age, infertility cause, basal FSH, BMI, the number of oocytes retrieved, number of M2 oocytes, embryo obtained and endometrial thickness between the two groups. But Serum estradiol, consumption of gonadotropins and ovarian hyperstimulation syndrome were significantly lower in the antagonist protocol. Cancellation rate of embryo transfer due to poor-quality embryo in the antagonist protocol was higher, but it was not significant. There was no significant difference in the clinical pregnancy and ongoing pregnancy between the two groups.

Conclusion: GnRH-antagonist is an effective, safe, and well-tolerated alternative to agonist in the first cycle of ART.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources